Copper in cancer: From pathogenesis to therapy

Area of Science:

• Biochemistry
• Oncology
• Trace Element Metabolism

Background:

• Copper is a vital trace element for human tissue structure and metabolism.
• Excessive copper intake or abnormal accumulation can cause cellular damage and disrupt redox balance, leading to cell death.
• Elevated serum and tumor copper levels are observed in various cancers, indicating a specific dependency of tumor cells on copper.

Purpose of the Study:

• To summarize the current understanding of the correlation between copper and cancer.
• To describe the characteristics of copper metabolism in tumor cells.
• To explore prospective applications of copper-derived therapeutics in cancer treatment.

Main Methods:

• Literature review and synthesis of existing research on copper's role in cancer.
• Analysis of copper metabolism pathways in neoplastic cells.
• Discussion of emerging copper-targeted therapeutic strategies.

Main Results:

• Tumor cells exhibit altered copper metabolism, requiring higher levels for proliferation compared to normal cells.
• Both copper deficiency and overload can negatively impact tumor cell viability.
• Copper-dependent signals present potential targets for novel cancer therapies.

Conclusions:

• Copper plays a dual role in human health, being essential at physiological levels but detrimental at excessive concentrations.
• Understanding tumor-specific copper metabolism is crucial for developing effective cancer treatments.
• Copper-based therapeutics offer promising avenues for cancer therapy, though their mechanisms require further elucidation.